PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT

May 1, 2009, 00:00
10.1016/S1098-3015(10)73350-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)73350-7/fulltext
Title : PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73350-7&doi=10.1016/S1098-3015(10)73350-7
First page :
Section Title :
Open access? : No
Section Order : 778
Categories :
Tags :
Regions :
ViH Article Tags :